Arthur L. Holmes, B.A.
President and Chief Executive Officer
Arthur L. Holmes, B.A. serves as President and Chief Executive Officer for PharPoint. Mr. Holmes is a seasoned industry professional with nearly 20 years of experience in the pharmaceutical industry, including extensive experience in pharmaceutical consulting and contract services. Prior to PharPoint, he founded Databasics Consulting, Inc., a company specializing in systems implementation and validation for pharmaceutical and biotechnology clients. Mr. Holmes has also held management positions at Quintiles Transnational Corp. and PharmaResearch Inc, subsequently known as Kendle International. In his capacity with these companies he provided leadership in both technical and operational strategies.
Audra G. McRae, B.S.
Chief Operating Officer
Audra G. McRae, B.S. serves as Chief Operating Officer for PharPoint. Ms. McRae has worked in data services for 19 years, with 17 of those years being in the CRO industry. Ms. McRae’s data management experience ranges from providing data management support and processing for laboratory and phase I through IV clinical trials to senior management oversight of staff and processes for large international data management departments. During her tenure at PharmaResearch Inc., subsequently known as Kendle International, Ms. McRae served as Director, Clinical Data Management for the Americas. Ms. McRae is a member of the Society for Clinical Data Management and served on the Board of Directors for the society from 2003 to 2005.
Jennifer A. Elder, Ph.D.
Vice President, Biostatistics and Consulting Services
Jennifer A. Elder, Ph.D. serves as Vice President of Biostatistics and Consulting Services for PharPoint. Dr. Elder has performed statistical analyses for clinical trials for 15 years, with 11 of those years being in the CRO industry. Dr. Elder served as the lead statistician on the pivotal studies for two novel compounds in a new class of antiretroviral medications in indications for the treatment of HIV and viral hepatitis. She participated in the completion of several NDA, MAA, sNDA, and IND applications and provided strategic consulting, clinical program development planning, and statistical analysis oversight for over 75 projects. Additionally, her experience includes providing statistical support for several pharmaceutical industry-sponsored pregnancy registries and phase I through IV clinical trials. Prior to her CRO experience, Dr. Elder was an Assistant Professor of Biostatistics and a statistical consultant at the University of North Carolina at Wilmington where she maintains an adjunct affiliation. Dr. Elder has participated in the authorship of many presentations and has been an invited speaker at several industry conferences.
Teresa S. Kilgallen, B.A.
Director, Data Management
Teresa S. Kilgallen, B.A. serves as Director of Data Management for PharPoint. Ms. Kilgallen received her B.A. in psychology with a concentration in research methodology from the College of Holy Cross. She has also completed coursework in epidemiology and has worked for over 14 years in clinical research, with the last 11 years being in the CRO industry. During her tenure in the industry, she has managed phase I through IV clinical trials, with particular emphasis on oversight of developmental programs, multi-national trials and EDC trials. She has worked in various therapeutic areas, including: oncology, antiviral, respiratory, endocrine/metabolic, gastrointestinal, ophthalmology and women’s health. In addition to project oversight, Ms Kilgallen provides senior management oversight for all data management services and assists with the development and implementation of corporate training programs.
Amy T. Flynt, Ph.D.
Manager, Biostatistics
Amy T. Flynt, Ph.D. serves as Manager of Biostatistics for PharPoint. Dr. Flynt received her Ph.D. in statistics from North Carolina State University. While completing her degree, she spent three years as an intern in the clinical statistics department at a major pharmaceutical company. Prior to joining PharPoint, she worked in the pharmaceutical industry for over five years where she served as a lead statistician and provided statistical support for phase I through IV clinical trials and pharmaceutical industry-sponsored pregnancy registries. She also has served as a DMC statistician and as a statistical consultant. Her work experience has spanned various therapeutic areas, including: psychiatric disorders, cardiovascular, virology, women’s health, respiratory, pain, and oncology.
